Clinical Trial Update: TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating tranexamic acid to reduce heavy menstrual bleeding in individuals anticoagulated for venous thromboembolism; currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Venous Thromboembolism

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Venous Thromboembolism, Venous Thromboses | Phase 4 | Status: NOT_YET_RECRUITING